Dr. MacVicar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3215
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2002 - 2005- University of MichiganResidency, Internal Medicine, 1999 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
IL State Medical License 2005 - 2026
MI State Medical License 1999 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma Start of enrollment: 2010 Dec 01
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Start of enrollment: 2023 Sep 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.Bradley C Carthon, Se Eun Kim, David F McDermott, Janice P Dutcher, Maneka Puligandla
Clinical Genitourinary Cancer. 2023-10-01 - 3 citationsLong-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia
European Urology. 2023-09-01 - Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.Tomi Jun, Noah M Hahn, Guru Sonpavde, Constantine Albany, Gary R MacVicar
The Oncologist. 2022-06-08
Other
- Treatment of metastatic urothelial cancer of the bladder and urinary tractMacVicar GR, Bellmunt J, Hussain M
http://www.uptodate.com/contents/treatment-of-metastatic-urothelial-cancer-of-the-bladder-and-urinar
UpToDate, Wolters Kluwer Health - 2012-07-02
Press Mentions
Western Illinois Trial Site Organization First to Enroll Patient in Global Clinical Trial Investigating New Drugs Targeting Advanced Kidney CancerJune 23rd, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
